Short-term and intermediate outcomes of cardiogenic shock and cardiac arrest patients supported by venoarterial extracorporeal membrane oxygenation

[1] van Diepen S(2017)Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association Circulation 136 e232-e268

[2] Katz JN(2014)Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States J Am Heart Assoc 3 e000590-1411

[3] Albert NM(2016)Sex-based disparities in incidence, treatment, and outcomes of cardiac arrest in the United States, 2003–2012 J Am Heart Assoc 5 e003704-7

[4] Kolte D(2008)Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock Crit Care Med 36 1404-561

[5] Khera S(2011)Extracorporeal cardiopulmonary resuscitation in patients with inhospital cardiac arrest: a comparison with conventional cardiopulmonary resuscitation Crit Care Med 39 1-311.e1

[6] Aronow WS(2008)Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis Lancet 372 554-21.e1

[7] Kim LK(2010)Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock J Thorac Cardiovasc Surg 139 302-88

[8] Looser P(2014)Resource use trends in extracorporeal membrane oxygenation in adults: an analysis of the nationwide inpatient sample 1998–2009 J Thorac Cardiovasc Surg 148 416-118

[9] Swaminathan RV(2015)Trends in U.S. extracorporeal membrane oxygenation use and outcomes: 2002–2012 Semin Thorac Cardiovasc Surg 27 81-917

[10] Combes A(2015)Towards a proactive therapy utilizing the modern spectrum of extracorporeal life support: a single-centre experience Perfusion 30 113-1630

[1] van Diepen S(2017)Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association Circulation 136 e232-e268

[2] Katz JN(2014)Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States J Am Heart Assoc 3 e000590-1411

[3] Albert NM(2016)Sex-based disparities in incidence, treatment, and outcomes of cardiac arrest in the United States, 2003–2012 J Am Heart Assoc 5 e003704-7

[4] Kolte D(2008)Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock Crit Care Med 36 1404-561

[5] Khera S(2011)Extracorporeal cardiopulmonary resuscitation in patients with inhospital cardiac arrest: a comparison with conventional cardiopulmonary resuscitation Crit Care Med 39 1-311.e1

[6] Aronow WS(2008)Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis Lancet 372 554-21.e1

[7] Kim LK(2010)Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock J Thorac Cardiovasc Surg 139 302-88

[8] Looser P(2014)Resource use trends in extracorporeal membrane oxygenation in adults: an analysis of the nationwide inpatient sample 1998–2009 J Thorac Cardiovasc Surg 148 416-118

[9] Swaminathan RV(2015)Trends in U.S. extracorporeal membrane oxygenation use and outcomes: 2002–2012 Semin Thorac Cardiovasc Surg 27 81-917

[10] Combes A(2015)Towards a proactive therapy utilizing the modern spectrum of extracorporeal life support: a single-centre experience Perfusion 30 113-1630